From netsci@awod.com  Wed Sep 17 11:24:50 1997
Received: from sumter.awod.com  for netsci@awod.com
	by www.ccl.net (8.8.3/950822.1) id LAA18703; Wed, 17 Sep 1997 11:03:15 -0400 (EDT)
Received: from [208.140.96.13] (chs0016.awod.com [208.140.96.16])
	by sumter.awod.com (8.8.7/8.8.5) with SMTP id LAA00460;
	Wed, 17 Sep 1997 11:03:08 -0400 (EDT)
X-Sender: arichon@awod.com
Message-Id: <v01530503b0455a2dfaf9@[208.140.96.13]>
Mime-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Date: Wed, 17 Sep 1997 11:00:59 +0100
To: chemistry@www.ccl.net
From: netsci@awod.com (Network Science)
Subject: Meeting Announcement for 1998 Charleston Conference
Cc: netsci@awod.com
Status: RO
Content-Length: 6041



               The 1998 Charleston Conference
  Innovative Techniques for New Lead Discovery and Development

                     March 9-11, 1998
                    Wild Dunes Resort
              Isle of Palms, South Carolina

At one time, pharmaceutical scientists studied the function and structure
of a novel biological target and spent years identifying and optimizing a
lead candidate.  Over the past few years, competitive pressures have forced
research to become more efficient.  Emerging new technologies such as
genomics, gene sequencing, transgenic animals, and molecular biology have
afforded large numbers of novel, clinically relevant biological targets.
High throughput screening and combinatorial chemistry have been used to
rapidly identify and optimize leads for these targets.  Additionally, the
complementary techniques of computational chemistry and cheminformatics
have been used to successfully leverage research information.

The invited lectures and round-table discussions to be held over two and
one-half days will focus on the successful integration of these
technologies in new lead discovery and development.  Participants will
explore the ways in which the industry is increasing the productivity of
the discovery process.  The outstanding group of invited session chairs and
speakers who will lead the meeting are listed below.

                   Monday, March 9

8:00 - 11:30  Informatics
              Session Chair: David Spellmeyer
              Director, Design Technology Applications
              CombiChem, Inc.

              Ajay Jain
              Principal Scientist, Computational Sciences
              MetaXen LLC

              Yvonne Martin
              Senior Project Leader
              Computer Assisted Molecular Design Project
              Abbott Laboratories

             Webb Andrews
              Research Investigator
              Glaxo Wellcome

12:30 - 3:30 High Throughput Screening in ADME/Toxicology
             Session Chair: Kate Johnston
             Head, Biomolecular Research
             Sphinx Pharmaceuticals, Eli Lilly

             Oliver Flint
             Principal Scientist
             Bristol-Myers Squibb

             Jerome Hochman
             Research Fellow
             Merck Research Laboratories

             Philip L. Smith
             Director, Drug Discovery
             SmithKline Beecham

6:00 - 7:00: Poster Session

7:00 - 8:30: Dinner
             Sponsored by Molecular Solutions, Inc.

8:30 - 10:30: Vendor Q&A

                     Tuesday, March 10

8:00 - 11:30: De Novo and Combinatorial Library Design
              Session Chair: Christine Humblet
              Senior Director
              Biomolecular Structure and Drug Design
              Parke-Davis Research, Warner Lambert

              Joe Eyermann
          Principal Research Scientist
              Dupont-Merck Pharmaceuticals

              Irwin ("Tack") D. Kuntz
              University of California, San Francisco

              William Ripka
              Senior Vice President, Chemical Research
              Corvas International, Inc.

12:30 - 3:30 Natural Products as a Source for New Leads
             Session Chair: John Devlin
             President
             ARRT International

             John Beutler
             Special Expert
             Laboratory of Drug Discovery Research and Development
             National Cancer Institute

             Donald E. Bierer
             Group Leader
             Medicinal Chemistry
             Shaman Pharmaceuticals, Inc.

             John P. Devlin
             President
             MicroBotanica, Inc

             Wilhelm Stahl
             Director of Screening
             Hoechst Marion Roussel

7:00 - 10:30: Tapas Party
              412 Carolina Boulevard

                            Wednesday, March 11

8:00 - 11:30:  Gene-Based Drug Design
               Session Chair: Susan Burgess
               Vice President
               Structural Bioinformatics, Inc.

                Leigh Anderson
                President and CSO
                Large Scale Biology Corporation

                Donald N. Halbert
                Director, Genomics and Molecular Biology
                Abbott Laboratories

                Mark Furth
                Chief Scientific Officer
                PPD Inc.

                     The Accommodations

The Wild Dunes conference center offers a variety of activities including
two world class golf courses, several tennis courts, and a heated pool.
Housing will be available beginning Saturday, March 7. To facilitate a
lively exchange of ideas with colleagues in a casual setting, attendance at
this meeting will be limited.



               Call For Poster Session Abstracts

Attendees who wish to present a paper in the Poster Session should submit
an abstract for approval by the Conference Organizing Committee on or
before October 31, 1997. The presenter for the poster must be listed as its
first author in the abstract, and each attendee is limited to one
presentation in the Poster Session. Abstracts should be limited to one
page, twelve point font and must contain:

   * The title of the presentation

   * The names, affiliations, and full contact information for
     each of the authors

   * The abstract. If structures are part of the abstract,
     please submit them separately as a ChemDraw or ISIS
     Draw formatted file.

The Charleston Conference Committee will notify authors of acceptance of
their poster by November 30. Please Note:  Only 10 posters will be accepted
for presentation at this conference.

If you would like to be contacted with additional details about the
meeting, please use this e-mail link and give us your name, e-mail address,
and telephone and Fax number.  Electronic registration is available at
http://www.netsci.org

Network Science Corporation
412 Carolina Blvd
Isle of Palms, SC 29451
Tel: (803)886-8775
Fax: (803)886-5924
E-mail: netsci@awod.com
URL: http://www.netsci.org






